Choose another resource? Discovery Phase R & D Analysis Phase Regulatory Investigation Phase Patent Research Phase Marketing Phase Asset Management Phase

Nulla vel nibh vel quam sollicitudin lobortis. Ut mattis lectus ex, at condimentum lorem rhoncus eget. Suspendisse vel neque eu sapien condimentum aliquam. (Based on your info so far, it would be beneficial for you to investigate further with World Drug Index, Drug News, and Incidence & Prevalence Database. Use Thomson Reuters Life Sciences Professional Services at any time for consultations.)

World Drug Index is an authoritative index for marketed and development drugs. With internationally-recognized drug names, synonyms, trade names, trivial names and trial preparation codes in one source, plus compound structures and activity data, it is ideal for finding instant answers to drug research and marketing queries. DETAILS
Every business day, Thomson Reuters Drug News selects the latest, most important drug discovery and development news, places it in context, and presents it online and as email alerts in a clear, concise format that makes it easy to discover the important facts at a glance. Drug News contains an archive of news covering drug R&D since 1996, with chemical structure images. DETAILS
The Incidence and Prevalence Database (IPD) is the most efficient way to look at the world’s epidemiology data. The IPD covers over 4,500 diseases, procedures, symptoms and other health issues for incidence, prevalence, morbidity, mortality, comorbidity, treated or diagnosed rates, cost and much more. DETAILS
We combine expert analysis in use of our content and technology assets, proprietary analytical and visualization tools, and deep expertise in the pharmaceutical and life sciences business so you can benefit from tailored solutions that meet your unique business needs for faster, more informed decisions with higher confidence. DETAILS